Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$1.01B |
| 2 |
Amazon
AMZN
|
+$972M |
| 3 |
Microsoft
MSFT
|
+$956M |
| 4 |
Williams Companies
WMB
|
+$871M |
| 5 |
Prologis
PLD
|
+$795M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.9B |
| 2 |
GGP
GGP Inc.
GGP
|
+$1.69B |
| 3 |
XL
XL Group Ltd.
XL
|
+$1.48B |
| 4 |
DCT
DCT Industrial Trust Inc.
DCT
|
+$902M |
| 5 |
ANDV
Andeavor
ANDV
|
+$680M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.37% |
| 2 | Financials | 15.14% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTPH
3151
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $6.2M | ﹤0.01% |
112,357
-1,884
| -2% | -$120K |
|
3152
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
| $6.2M | ﹤0.01% |
44,488
+736
| +2% | +$103K |
|
|
ODT
3153
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $6.15M | ﹤0.01% |
316,733
+49,528
| +19% | +$1.01M |
|
|
CETV
3154
DELISTED
Central European Media Enterprises Ltd
CETV
| $6.14M | ﹤0.01% |
1,638,471
+97,335
| +6% | +$368K |
|
|
MBCN
3155
DELISTED
Middlefield Banc Corp
MBCN
| $6.13M | ﹤0.01% |
260,286
+598
| +0.2% | +$14.8K |
|
|
LONE
3156
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
| $6.12M | ﹤0.01% |
785,396
| – | – |
|
3157
IDT Corp
IDT
$1.62B
| $6.06M | ﹤0.01% |
1,134,560
-587,299
| -34% | -$3.15M |
|
|
MRSN
3158
DELISTED
Mersana Therapeutics
MRSN
| $6.01M | ﹤0.01% |
24,044
+6,157
| +34% | +$2.06M |
|
3159
Cue Biopharma
CUE
$114M
| $5.99M | ﹤0.01% |
22,054
-224
| -1% | -$64.7K |
|
3160
Pixelworks
PXLW
$41.6M
| $5.98M | ﹤0.01% |
110,557
+2,671
| +2% | +$134K |
|
|
TUES
3161
DELISTED
Tuesday Morning Corp
TUES
| $5.98M | ﹤0.01% |
1,867,651
+3,279
| +0.2% | +$9.7K |
|
3162
Scholar Rock
SRRK
$6.44B
| $5.97M | ﹤0.01% |
231,656
+191,656
| +479% | +$3.52M |
|
3163
Lifetime Brands
LCUT
$210M
| $5.96M | ﹤0.01% |
546,443
-1,050
| -0.2% | -$12.5K |
|
3164
Syndax Pharmaceuticals
SNDX
$1.82B
| $5.95M | ﹤0.01% |
736,604
-26,336
| -3% | -$188K |
|
3165
Union Bankshares
UNB
$109M
| $5.95M | ﹤0.01% |
111,923
+1,013
| +0.9% | +$53.2K |
|
3166
Gyre Therapeutics
GYRE
$744M
| $5.95M | ﹤0.01% |
73,558
-327
| -0.4% | -$25.9K |
|
|
IVTY
3167
DELISTED
Invuity, Inc
IVTY
| $5.95M | ﹤0.01% |
803,635
+29,592
| +4% | +$142K |
|
|
INFI
3168
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $5.92M | ﹤0.01% |
2,185,823
+6,168
| +0.3% | +$12.8K |
|
|
FFNW
3169
DELISTED
First Financial Northwest, Inc
FFNW
| $5.92M | ﹤0.01% |
357,102
+12,325
| +4% | +$224K |
|
|
EMKR
3170
DELISTED
Emcore Corp
EMKR
| $5.89M | ﹤0.01% |
124,000
+5,333
| +4% | +$259K |
|
|
ORBK
3171
DELISTED
Orbotech Ltd
ORBK
| $5.85M | ﹤0.01% |
98,398
+4,722
| +5% | +$295K |
|
3172
Peoples Bancorp of North Carolina
PEBK
$229M
| $5.84M | ﹤0.01% |
202,353
-599
| -0.3% | -$18.4K |
|
|
MCF
3173
DELISTED
Contango Oil & Gas Co.
MCF
| $5.83M | ﹤0.01% |
942,939
+284
| +0% | +$1.68K |
|
3174
Gilat Satellite Networks
GILT
$848M
| $5.82M | ﹤0.01% |
680,383
| – | – |
|
3175
Corvus Pharmaceuticals
CRVS
$1.17B
| $5.82M | ﹤0.01% |
677,974
+13,578
| +2% | +$136K |
|
Similar funds
Vanguard Group's Q3 2018 Portfolio in Review
As of Q3 2018, Vanguard Group held 4,228 positions worth $2.56T, up 7% from $2.39T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2018: portfolio turnover was 3.7%. Vanguard Group opened 96 new positions and exited 59, leaving the 4,228-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q3 2018 buy was KKR & Co: 37,674,357 shares worth $1.03B.
- Vanguard Group added most to Amazon in Q3 2018, an estimated $972M increase.
- Vanguard Group's biggest Q3 2018 reduction was Apple, cutting an estimated $1.9B.
- Vanguard Group fully exited GGP Inc. in Q3 2018, selling an estimated $1.69B.
- Vanguard Group's ten largest holdings make up 15% of its $2.56T portfolio in Q3 2018.
- Vanguard Group opened 96 new positions and closed 59 in Q3 2018.
- Vanguard Group's portfolio value rose 7% quarter-over-quarter to $2.56T.
Based on Vanguard Group's 13F filing for Q3 2018, filed 14 Nov 2018.